Product Category
Long-Acting Growth Hormone Releasing Hormone (GHRH) Analogs
Action on the Human Body
CJC-1295 with DAC (Drug Affinity Complex) is an extended-duration synthetic analog of Growth Hormone Releasing Hormone (GHRH). It features a reactive maleimide group covalently bound to the C-terminus, which attaches to circulating plasma albumin after introduction. This albumin-binding mechanism shields the peptide from enzymatic degradation and renal clearance, extending its active elimination half-life to roughly 6-8 days. Once in circulation, it provides steady, non-pulsatile activation of pituitary GHRH receptors, driving continuous baseline elevations of endogenous Growth Hormone (GH) and hepatic Insulin-like Growth Factor 1 (IGF-1). This continuous elevation results in sustained systemic lipolysis, constant muscle nitrogen retention, and prolonged connective tissue matrix rebuilding over multi-day periods.






Reviews
There are no reviews yet.